Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
Open accessThe DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.
Abstract
Recent clinical data on vancomycin pharmacokinetics and pharmacodynamics suggest a reevaluation of current dosing and monitoring recommendations. The previous 2009 vancomycin consensus guidelines recommend trough monitoring as a surrogate marker for the target area under the curve over 24 hours to minimum inhibitory concentration (AUC/MIC). However, recent data suggest that trough monitoring is associated with higher nephrotoxicity. This document is an executive summary of the new vancomycin consensus guidelines for vancomycin dosing and monitoring. It was developed by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists vancomycin consensus guidelines committee. These consensus guidelines recommend an AUC/MIC ratio of 400-600 mg*hour/L (assuming a broth microdilution MIC of 1 mg/L) to achieve clinical efficacy and ensure safety for patients being treated for serious methicillin-resistant Staphylococcus aureus infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
KDIGO Clinical Practice Guidelines for Acute Kidney Injury
Khwaja, A. (2012) · Nephron Clinical Practice · doi:10.1159/000339789 · Cited by 8,014
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
Mehta, R. L., Kellum, J. A., Shah, S. V., Molitoris, B. A., Ronco, C., Warnock, D. G., Levin, A., & the Acute Kidney Injury Network (2007) · Critical Care · doi:10.1186/cc5713 · Cited by 7,048
Prevalence of Obesity Among Adults and Youth: United States, 2015-2016.
Hales, C. M., Carroll, M. D., Fryar, C. D., & Ogden, C. L. (2017) · PubMed · Cited by 4,508
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,191
Self-citation(1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.4.899 · Cited by 2,700
Rybak, M., Lomaestro, B., Rotschafer, J. C., Moellering, R., Craig, W., Billeter, M., Dalovisio, J. R., & Levine, D. P. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080434 · Cited by 1,795 · cited 8×
“loading doses for severe infections in patients who were seriously ill.(1)”
BackgroundMethodResultInfluentialSelf-citationLiu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir034 · Cited by 1,599
Self-citationAntimicrobial pharmacodynamics: critical interactions of 'bug and drug'
Drusano, G. L. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro862 · Cited by 930
Hidayat, L. K., Hsu, D. I., Quist, R., Shriner, K. A., & Wong-Beringer, A. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.19.2138 · Cited by 860
Self-citationThe Pharmacokinetic and Pharmacodynamic Properties of Vancomycin
Rybak, M. J. (2006) · Clinical Infectious Diseases · doi:10.1086/491712 · Cited by 774
Self-citationMoise-Broder, P. A., Forrest, A., Birmingham, M. C., & Schentag, J. J. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443130-00005 · Cited by 757
van Hal, S. J., Paterson, D. L., & Lodise, T. P. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01568-12 · Cited by 639
Self-citationLodise, T. P., McKinnon, P. S., Swiderski, L., & Rybak, M. J. (2003) · Clinical Infectious Diseases · doi:10.1086/375057 · Cited by 604
Self-citationLodise, T. P., Lomaestro, B., Graves, J., & Drusano, G. L. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01602-07 · Cited by 574
Self-citationAKI in the ICU: definition, epidemiology, risk stratification, and outcomes
Singbartl, K., & Kellum, J. A. (2012) · Kidney International · doi:10.1038/ki.2011.339 · Cited by 563
Craig, W. A. (2003) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(03)00065-5 · Cited by 556
Lodise, T. P., Patel, N., Lomaestro, B. M., Rodvold, K. A., & Drusano, G. L. (2009) · Clinical Infectious Diseases · doi:10.1086/600884 · Cited by 554
Self-citationLodise, T. P., Graves, J., Evans, A., Graffunder, E., Helmecke, M., Lomaestro, B. M., & Stellrecht, K. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00113-08 · Cited by 553
Self-citationHuman renal function maturation: a quantitative description using weight and postmenstrual age
Rhodin, M. M., Anderson, B. J., Peters, A. M., Coulthard, M. G., Wilkins, B., Cole, M., Chatelut, E., Grubb, A., Veal, G. J., Keir, M. J., et al. (2009) · Pediatric Nephrology · doi:10.1007/s00467-008-0997-5 · Cited by 497
Kullar, R., Davis, S. L., Levine, D. P., & Rybak, M. J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir124 · Cited by 463
Self-citationMatzke, G. R., Aronoff, G. R., Atkinson, A. J., Bennett, W. M., Decker, B. S., Eckardt, K.-U., Golper, T., Grabe, D. W., Kasiske, B., Keller, F., et al. (2011) · Kidney International · doi:10.1038/ki.2011.322 · Cited by 462 · cited 2×
“There is considerable controversy regarding the optimal body size metric for this calculation in obese patients.(124) The Cockcroft-Gault equation predates the global standardization of Scr measurement traceable to isotopic-dilution mass spectrometry (IDMS) standards advocated to reduce intralaboratory and interlabora…”
BackgroundMethodSelf-citationA suggested approach to once‐daily aminoglycoside dosing.
Begg, E., Barclay, M., & Duffull, S. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb05719.x · Cited by 420
Are Vancomycin Trough Concentrations Adequate for Optimal Dosing?
Neely, M. N., Youn, G., Jones, B., Jelliffe, R. W., Drusano, G. L., Rodvold, K. A., & Lodise, T. P. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01653-13 · Cited by 392
Self-citationWysocki, M., Delatour, F., Faurisson, F., Rauss, A., Pean, Y., Misset, B., Thomas, F., Timsit, J.-F., Similowski, T., Mentec, H., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2460-2467.2001 · Cited by 385
Neely, M. N., Kato, L., Youn, G., Kraler, L., Bayard, D., van Guilder, M., Schumitzky, A., Yamada, W., Jones, B., & Minejima, E. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02042-17 · Cited by 359
Jeffres, M. N., Isakow, W., Doherty, J. A., Micek, S. T., & Kollef, M. H. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.06.014 · Cited by 334
Innovative approaches to optimizing the delivery of vancomycin in individual patients
Pai, M. P., Neely, M., Rodvold, K. A., & Lodise, T. P. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.016 · Cited by 292
Self-citationTong, S. Y. C., Lye, D. C., Yahav, D., Sud, A., Robinson, J. O., Nelson, J., Archuleta, S., Roberts, M. A., Cass, A., Paterson, D. L., et al. (2020) · JAMA · doi:10.1001/jama.2020.0103 · Cited by 279
Improved Vancomycin Dosing in Children Using Area Under the Curve Exposure
Le, J., Bradley, J. S., Murray, W., Romanowski, G. L., Tran, T. T., Nguyen, N., Cho, S., Natale, S., Bui, I., Tran, T. M., et al. (2013) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318286378e · Cited by 262
Self-citationVancomycin pharmacokinetics in patients with various degrees of renal function
Rodvold, K. A., Blum, R. A., Fischer, J. H., Zokufa, H. Z., Rotschafer, J. C., Crossley, K. B., & Riff, L. J. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.6.848 · Cited by 249
Self-citationVancomycin: We Can't Get There From Here
Patel, N., Pai, M. P., Rodvold, K. A., Lomaestro, B., Drusano, G. L., & Lodise, T. P. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir078 · Cited by 247
Self-citationFinch, N. A., Zasowski, E. J., Murray, K. P., Mynatt, R. P., Zhao, J. J., Yost, R., Pogue, J. M., & Rybak, M. J. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01293-17 · Cited by 241
Self-citationVancomycin pharmacokinetics in normal and morbidly obese subjects
Blouin, R. A., Bauer, L. A., Miller, D. D., Record, K. E., & Griffen, W. O. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.21.4.575 · Cited by 233
Roberts, J. A., Taccone, F. S., Udy, A. A., Vincent, J.-L., Jacobs, F., & Lipman, J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01708-10 · Cited by 226 · cited 1×
“Loading doses of 25 to 35 mg/kg will require infusion times of at least 2 to 3 hours.(99) After administration of the loading dose, the initiation of the maintenance dose should occur at the next dosing interval (eg, an interval of every 6 hours indicates initiating the maintenance dose 6 hours after the start of the…”
BackgroundVancomycin: A Review of Population Pharmacokinetic Analyses
Marsot, A., Boulamery, A., Bruguerolle, B., & Simon, N. (2012) · Clinical Pharmacokinetics · doi:10.2165/11596390-000000000-00000 · Cited by 226
Vancomycin AUC/MIC Ratio and 30-Day Mortality in Patients with Staphylococcus aureus Bacteremia
Holmes, N. E., Turnidge, J. D., Munckhof, W. J., Robinson, J. O., Korman, T. M., O'Sullivan, M. V. N., Anderson, T. L., Roberts, S. A., Warren, S. J. C., Gao, W., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01485-12 · Cited by 224
Diekema, D. J., Pfaller, M. A., Shortridge, D., Zervos, M., & Jones, R. N. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy270 · Cited by 221
Burgess, L. D., & Drew, R. H. (2014) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1442 · Cited by 205
Linder, A., Fjell, C., Levin, A., Walley, K. R., Russell, J. A., & Boyd, J. H. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201311-2097oc · Cited by 199
Vancomycin Area Under the Curve and Acute Kidney Injury: A Meta-analysis
Aljefri, D. M., Avedissian, S. N., Rhodes, N. J., Postelnick, M. J., Nguyen, K., & Scheetz, M. H. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz051 · Cited by 199
Pai, M. P. (2012) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.2012.01108.x · Cited by 193
Self-citationIncidence and Risk Factors Influencing the Development of Vancomycin Nephrotoxicity in Children
McKamy, S., Hernandez, E., Jahng, M., Moriwaki, T., Deveikis, A., & Le, J. (2011) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.08.019 · Cited by 186
Self-citationMohr, J. F., & Murray, B. E. (2007) · Clinical Infectious Diseases · doi:10.1086/518451 · Cited by 185
Navalkele, B., Pogue, J. M., Karino, S., Nishan, B., Salim, M., Solanki, S., Pervaiz, A., Tashtoush, N., Shaikh, H., Koppula, S., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw709 · Cited by 184
Self-citationGomes, D. M., Smotherman, C., Birch, A., Dupree, L., Della Vecchia, B. J., Kraemer, D. F., & Jankowski, C. A. (2014) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1428 · Cited by 180
Vancomycin and the Risk of AKI: A Systematic Review and Meta-Analysis
Sinha Ray, A., Haikal, A., Hammoud, K. A., & Yu, A. S. L. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05920616 · Cited by 175
Hsu, D. I., Hidayat, L. K., Quist, R., Hindler, J., Karlsson, A., Yusof, A., & Wong-Beringer, A. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.05.007 · Cited by 173
Self-citationLodise, T. P., Drusano, G. L., Zasowski, E., Dihmess, A., Lazariu, V., Cosler, L., & McNutt, L.-A. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu398 · Cited by 167
Self-citationBenchmarking Therapeutic Drug Monitoring Software: A Review of Available Computer Tools
Fuchs, A., Csajka, C., Thoma, Y., Buclin, T., & Widmer, N. (2013) · Clinical Pharmacokinetics · doi:10.1007/s40262-012-0020-y · Cited by 165
Zasowski, E. J., Murray, K. P., Trinh, T. D., Finch, N. A., Pogue, J. M., Mynatt, R. P., & Rybak, M. J. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01684-17 · Cited by 165
Self-citationRoy, A. K., Mc Gorrian, C., Treacy, C., Kavanaugh, E., Brennan, A., Mahon, N. G., & Murray, P. T. (2013) · Cardiorenal Medicine · doi:10.1159/000347037 · Cited by 164
Ingram, P. R., Lye, D. C., Tambyah, P. A., Goh, W. P., Tam, V. H., & Fisher, D. A. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn080 · Cited by 163
Vancomycin dosing in morbidly obese patients
Bauer, L. A., Black, D. J., & Lill, J. S. (1998) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050524 · Cited by 162
Cano, E. L., Haque, N. Z., Welch, V. L., Cely, C. M., Peyrani, P., Scerpella, E. G., Ford, K. D., Zervos, M. J., Ramirez, J. A., & Kett, D. H. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.12.013 · Cited by 161
Frymoyer, A. R., Hersh, A. L., Benet, L. Z., & Guglielmo, B. J. (2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181906e40 · Cited by 146
Vancomycin Pharmacokinetics in a Patient Population
Ducharme, M. P., Slaughter, R. L., & Edwards, D. J. (1994) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199410000-00013 · Cited by 146
Applied Clinical Pharmacokinetics
(2001) · Annals of Pharmacotherapy · doi:10.1345/aph.1br01l · Cited by 138
Turner, R. B., Kojiro, K., Shephard, E. A., Won, R., Chang, E., Chan, D., & Elbarbry, F. (2018) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2191 · Cited by 135 · cited 1×
“Bayesian dose-optimizing software programs are now readily available and can be used in real time to identify the optimal vancomycin dosage that readily achieves the AUC target (assuming a MIC BMD of 1 mg/L).(66,68) Bayesian programs offer numerous advantages over the traditional first-order equation software programs.”
BackgroundBrown, J. E., Brown, K., & Forrest, A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05609-11 · Cited by 126
Suzuki, Y., Kawasaki, K., Sato, Y., Tokimatsu, I., Itoh, H., Hiramatsu, K., Takeyama, M., & Kadota, J. (2012) · Chemotherapy · doi:10.1159/000343162 · Cited by 124
Zimmermann, A. E., Katona, B. G., & Plaisance, K. I. (1995) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1995.tb04335.x · Cited by 123
Pea, F., Furlanut, M., Negri, C., Pavan, F., Crapis, M., Cristini, F., & Viale, P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01149-08 · Cited by 118
Vance‐Bryan, K., Guay, D. R. P., Gilliland, S. S., Rodvold, K. A., & Rotschafer, J. C. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.3.436 · Cited by 114
Self-citationKielstein, J. T., Czock, D., Schoepke, T., Hafer, C., Bode‐Böger, S. M., Kuse, E. R., Keller, F., & Fliser, D. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000190243.88133.3f · Cited by 113
Use of vancomycin in high-flux hemodialysis: Experience with 130 courses of therapy
Barth, R. H., & DeVincenzo, N. (1996) · Kidney International · doi:10.1038/ki.1996.393 · Cited by 112
Vancomycin-Associated Nephrotoxicity in the Critically Ill
Hanrahan, T. P., Harlow, G., HUTCHINSON, J. H., Dulhunty, J. M., Lipman, J., Whitehouse, T., & Roberts, J. A. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000514 · Cited by 111
Kullar, R., Leonard, S. N., Davis, S. L., Delgado, G., Pogue, J. M., Wahby, K. A., Falcione, B. A., & Rybak, M. J. (2011) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.31.5.441 · Cited by 109
Self-citationMouton, J. W., Meletiadis, J., Voß, A., & Turnidge, J. D. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky232 · Cited by 109
Colin, P. J., Allegaert, K., Thomson, A. H., Touw, D. J., Dolton, M. J., de Hoog, M., Roberts, J. A., Adane, E. D., Yamamoto, M., Buelga, D. S., et al. (2019) · Clinical Pharmacokinetics · doi:10.1007/s40262-018-0727-5 · Cited by 106
Grace, E. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks066 · Cited by 105
Adane, E. D., Herald, M., & Koura, F. A. (2015) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1531 · Cited by 104
Pharmacokinetics and Drug Dosing in Obese Children
Kendrick, J. G., Carr, R. R., & Ensom, M. H. H. (2010) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-15.2.94 · Cited by 104
Hermsen, E. D., Hanson, M., Sankaranarayanan, J., Stoner, J. A., Florescu, M. C., & Rupp, M. E. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330903413514 · Cited by 102
Casapao, A. M., Lodise, T. P., Davis, S. L., Claeys, K. C., Kullar, R., Levine, D. P., & Rybak, M. J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03970-14 · Cited by 101
Self-citationAssessment of Vancomycin Dosing and Subsequent Serum Concentrations in Pediatric Patients
Eiland, L. S., English, T. M., & Eiland, E. H. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1p588 · Cited by 101
Diaz, R., Afreixo, V. M. A., Ramalheira, E., Rodrigues, C., & Gago, B. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.06.017 · Cited by 101
Jung, Y., Song, K., Cho, J. E., Kim, H.-S., Kim, N., Kim, T. S., Choe, P. G., Chung, J., Park, W. B., Bang, J. H., et al. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.10.017 · Cited by 99
Minejima, E., Choi, J. J., Beringer, P. M., Lou, M., Tse, E., & Wong‐Beringer, A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00173-11 · Cited by 94
Self-citationRybak, M. J., Vidaillac, C., Sader, H. S., Rhomberg, P. R., Salimnia, H., Briski, L. E., Wanger, A. R., & Jones, R. N. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00448-13 · Cited by 94
Self-citationMoenster, R. P., Linneman, T. W., Finnegan, P. M., Hand, S., Thomas, Z., & McDonald, J. R. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12410 · Cited by 90
Making the change to area under the curve–based vancomycin dosing
Heil, E. L., Claeys, K. C., Mynatt, R. P., Hopkins, T. L., Brade, K. D., Watt, I., Rybak, M. J., & Pogue, J. M. (2018) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp180034 · Cited by 86
Self-citationHutschala, D., Kinstner, C. M., Skhirdladze, K., Thalhammer, F., Müller, M., & Tschernko, E. (2009) · Anesthesiology · doi:10.1097/aln.0b013e3181a97272 · Cited by 85
Gawronski, K. M., Goff, D. A., Brown, J. E., Khadem, T. M., & Bauer, K. A. A. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.05.008 · Cited by 74
Continuous Versus Intermittent Vancomycin Infusions in Infants: A Randomized Controlled Trial
Gwee, A., Cranswick, N., McMullan, B. J., Perkins, E., Bolisetty, S., Gardiner, K., Daley, A. J., Ward, M. C., Chiletti, R., Donath, S. M., et al. (2019) · PEDIATRICS · doi:10.1542/peds.2018-2179 · Cited by 74
Ingram, P. R., Lye, D. C., Fisher, D. A., Goh, W.-P., & Tam, V. H. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.07.011 · Cited by 73
Vancomycin toxicity in neonates
Lestner, J. M., Hill, L. F., Heath, P. T., & Sharland, M. (2016) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000263 · Cited by 73
Necessity of a loading dose when using vancomycin in critically ill patients
Wang, J.-T. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.2.246 · Cited by 72
Factors Associated With Acute Kidney Injury in Children Receiving Vancomycin
Sinclair, E. A., Yenokyan, G., McMunn, A., Fadrowski, J. J., Milstone, A. M., & Lee, C. K. K. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014549185 · Cited by 69
Nephrotoxicity With Vancomycin in the Pediatric Population
Fiorito, T. M., Luther, M. K., Dennehy, P. H., LaPlante, K. L., & Matson, K. L. (2017) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001882 · Cited by 68
Evaluation of Vancomycin Dosing Regimens in Preterm and Term Neonates Using Monte Carlo Simulations
Mehrotra, N., Tang, L. E., Phelps, S. J., & Meibohm, B. (2012) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.2012.01029.x · Cited by 65
A Bayesian Approach to Tracking Patients Having Changing Pharmacokinetic Parameters
Bayard, D. S., & Jelliffe, R. W. (2004) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1023/b:jopa.0000029490.76908.0c · Cited by 64
Karino, S., Kaye, K. S., Navalkele, B. D., Nishan, B., Salim, M., Solanki, S., Pervaiz, A., Tashtoush, N., Shaikh, H., Koppula, S., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03011-15 · Cited by 63
Self-citationMogle, B. T., Steele, J. M., Seabury, R. W., Dang, U. J., & Kufel, W. D. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.08.024 · Cited by 63
Truong, J. Q., Levkovich, B., & Padiglione, A. A. (2012) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2011.02459.x · Cited by 62
Ocampos-Martinez, E., Penaccini, L., Scolletta, S., Abdelhadii, A., Devigili, A., Cianferoni, S., Backer, D. D., Jacobs, F., COTTON, F. J., Vincent, J., et al. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.12.008 · Cited by 62
Continuous intravenous administration of vancomycin in medical intensive care unit patients
Saugel, B., Nowack, M., Hapfelmeier, A., Umgelter, A., Schultheiß, C., Thies, P., Phillip, V., Eyer, F., Schmid, R. M., & Huber, W. (2012) · Journal of Critical Care · doi:10.1016/j.jcrc.2012.02.003 · Cited by 56
Dosing vancomycin in the super obese: less is more
Crass, R. L., Dunn, R. D., Hong, J., Krop, L. C., & Pai, M. P. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky310 · Cited by 54
Self-citationMcNeil, J. C., Kok, E. Y., Forbes, A., Lamberth, L. B., Hultén, K. G., Vallejo, J. G., Mason, E. O., & Kaplan, S. L. (2015) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000991 · Cited by 53
Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients
Chaijamorn, W., Jitsurong, A., Wiwattanawongsa, K., Wanakamanee, U., & Dandecha, P. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.04.010 · Cited by 52
Vancomycin Monitoring in Children Using Bayesian Estimation
Lê, J., Ngu, B., Bradley, J. S., Murray, W. S., Nguyen, A., Nguyen, L., Romanowski, G. L., Vo, T., & Capparelli, E. V. (2014) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000039 · Cited by 51
Self-citationLi, J., Udy, A. A., Kirkpatrick, C. M. J., Lipman, J., & Roberts, J. A. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.08.017 · Cited by 51
Hong, J., Krop, L. C., Johns, T. L., & Pai, M. P. (2015) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1588 · Cited by 48
Self-citationTafelski, S., Nachtigall, I., Troeger, U., Deja, M., Krannich, A., Günzel, K., & Spies, C. (2015) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2015.01.011 · Cited by 48
Late-Occurring Vancomycin-Associated Acute Kidney Injury in Children Receiving Prolonged Therapy
Knoderer, C. A., Gritzman, A. L., Nichols, K. R., & Wilson, A. C. (2015) · Annals of Pharmacotherapy · doi:10.1177/1060028015594190 · Cited by 48
Akers, K. S., Cota, J. M., Chung, K. K., Renz, E. M., Mende, K., & Murray, C. K. (2012) · Journal of Burn Care & Research · doi:10.1097/bcr.0b013e31825042fa · Cited by 47
Vancomycin Trough Concentrations in Overweight or Obese Pediatric Patients
Heble, D. E., McPherson, C. C., Nelson, M. P., & Hunstad, D. A. (2013) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1321 · Cited by 47
Al‐Sulaiti, F. K., Nader, A. M., Saad, M. O., Shaukat, A., Parakadavathu, R., Elzubair, A. G., Al‐Badriyeh, D., Elewa, H. F., & Awaisu, A. (2019) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-019-00551-1 · Cited by 47
Avedissian, S. N., Pais, G. M., O’Donnell, J. N., Lodise, T. P., Liu, J., Prozialeck, W. C., Joshi, M. D., Lamar, P. C., Becher, L., Gulati, A., et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz167 · Cited by 47
Self-citationVancomycin Use in Patients Requiring Hemodialysis: A Literature Review
Cardone, K. E., & Manley, H. J. (2007) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2007.00333.x · Cited by 46
Incidence and Predisposing Factors of Vancomycin-Induced Nephrotoxicity in Children
Ragab, A. R., Al-Mazroua, M. K., & Al-Haroony, M. A. (2013) · Infectious Diseases and Therapy · doi:10.1007/s40121-013-0004-8 · Cited by 46
Choi, Y. C., Saw, S., Soliman, D., Bingham, A. L., Pontiggia, L., Hunter, K. M., Chuang, L. C., Siemianowski, L. A., Ereshefsky, B. J., & Hollands, J. M. (2017) · Annals of Pharmacotherapy · doi:10.1177/1060028017720946 · Cited by 46
Hahn, A., Frenck, R. W., Staat, M. A., Zou, Y., & Vinks, A. A. T. M. M. (2015) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000190 · Cited by 45
Vidaillac, C., Gardete, S., Tewhey, R., Sakoulas, G., Kaatz, G. W., Rose, W. E., Tomasz, A., & Rybak, M. J. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit127 · Cited by 45
Self-citationThe Effect of Age and Weight on Vancomycin Serum Trough Concentrations in Pediatric Patients
Madigan, T., Sieve, R. M., Graner, K. K., & Banerjee, R. (2013) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1331 · Cited by 44
Carreno, J. J., Lomaestro, B. M., Tietjan, J., & Lodise, T. P. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02478-16 · Cited by 44
Self-citationScoville, B. A., & Mueller, B. A. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.08.042 · Cited by 43
Self-citationVancomycin pharmacokinetics and predicted dosage requirements in pediatric cancer patients
Hadi, O. A., Omar, S. A., Nazer, L. H., Mubarak, S., & Lê, J. (2015) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155215591386 · Cited by 43
Chung, J., Oh, J. M., Cho, E. M., Jang, H. J., Hong, S., Lim, C., & Koh, Y. S. (2011) · Anaesthesia and Intensive Care · doi:10.1177/0310057x1103900608 · Cited by 42
Loading dose of vancomycin in critically ill patients: 15mg/kg is a better choice than 500mg
Mohammédi, I., Descloux, É., Argaud, L., LESCANFF, J., & Robert, D. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.11.009 · Cited by 41
Zhang, H., Wang, Y., Gao, P., Hu, J., Chen, Y., Zhang, L., Shen, X., Xu, H., & Xu, Q. (2015) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.653 · Cited by 39
A propensity-matched cohort study of vancomycin-associated nephrotoxicity in neonates
Constance, J. E., Balch, A. H., Stockmann, C. R., Linakis, M. W., Korgenski, E. K., Roberts, J. K., Ward, R. M., Sherwin, C. M. T., & Spigarelli, M. G. (2015) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/archdischild-2015-308459 · Cited by 39
Kralovicová, K., Spanik, S., Halko, J., Netriová, J., Mrazova-Studena, M., Novotný, J., Grausova, S., Koren, P., Krupova, I., Demitrovicova, A., et al. (1997) · Journal of Chemotherapy · doi:10.1179/joc.1997.9.6.420 · Cited by 38
Zelenitsky, S. A., Ariano, R. E., McCrae, M. L., & Vercaigne, L. M. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis458 · Cited by 37
Dubée, V., Zeller, V., Lhotellier, L., Kitzis, M.-D., Ziza, J.-M., Mamoudy, P., & Desplaces, N. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12071 · Cited by 37
Vandecasteele, S. J., Bacquer, D. D., & Vriese, A. S. D. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir337 · Cited by 35
Vancomycin dosage in overweight and obese children
Miller, M. M., Miller, J. L., Hagemann, T. M., Harrison, D. L., Chávez‐Bueno, S., & Johnson, P. N. (2011) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp110107 · Cited by 35
Waele, J. J. D., Danneels, I., Depuydt, P. O., Decruyenaere, J. M. A., Bourgeois, M., & Hoste, E. A. J. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.12.015 · Cited by 34
Pediatric Obesity: Pharmacokinetic Alterations and Effects on Antimicrobial Dosing
Natale, S., Bradley, J. S., Nguyen, W. H., Tran, T. M., Ny, P., La, K. P., Vivian, E., & Lê, J. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1899 · Cited by 34
Self-citationA Randomized Controlled Trial of a Vancomycin Loading Dose in Children
Demirjian, A., Finkelstein, Y., Nava‐Ocampo, A. A., Arnold, A. D., Jones, S. M., Monuteaux, M. C., Sandora, T. J., Patterson, A., & Harper, M. B. (2013) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3182a26774 · Cited by 28
Weight-Based Loading of Vancomycin in Patients on Hemodialysis
Brown, M., Polisetty, R. S., Gracely, E. J., Çuhaci, B., & Schlecht, H. P. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir322 · Cited by 28
Cies, J. J., Moore, W. S., Nichols, K. R., Knoderer, C. A., Carella, D. M., & Chopra, A. (2017) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000001250 · Cited by 28
Vancomycin D osing in C hildren and Y oung A dults: B ack to the D rawing B oard
Camaione, L., Elliott, K., Steele, A. M.-V., Lomaestro, B. M., & Pai, M. P. (2013) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1345 · Cited by 27
Self-citationHarris, L. E., Reaves, A. B., Krauss, A. G., Griner, J., & Hudson, J. Q. (2012) · International Journal of Pharmacy Practice · doi:10.1111/j.2042-7174.2012.00226.x · Cited by 24
Yoo, R. N., Kim, S., & Lee, J. (2016) · Journal of Korean Medical Science · doi:10.3346/jkms.2017.32.1.22 · Cited by 24
Evaluation of vancomycin MIC creep in Staphylococcus aureus
Diaz, R., Ramalheira, E., Afreixo, V. M. A., et al. (2017) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2017.04.007 · Cited by 24
Ploessl, C., White, C., & Manasco, K. B. (2015) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000817 · Cited by 23
Fu, C.-F., Huang, J.-D., Wang, J., Lin, S., & Wu, C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193585 · Cited by 23
Stockmann, C. R., Olson, J. A., Rashid, J., Lubsch, L. M., Young, D. C., Hersh, A. L., Frymoyer, A. R., Ampofo, K., Liu, X., Wang, Y., et al. (2018) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1323 · Cited by 22
Matson, K. L., Shaffer, C. L., Beck, G. L., & Simonsen, K. A. (2015) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1552 · Cited by 21
Peak Measurement for Vancomycin AUC Estimation in Obese Adults Improves Precision and Lowers Bias
Pai, M. P., Hong, J., & Krop, L. C. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02490-16 · Cited by 21
Self-citationNassar, L., Hadad, S., Gefen, A., Shachor‐Meyouhas, Y., Mashiach, T., Krivoy, N., & Kassis, I. (2012) · Current Drug Safety · doi:10.2174/1574886311207050009 · Cited by 20
Singh, N. B., Yim, J., Jahanbakhsh, S., Sakoulas, G., & Rybak, M. J. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.03.020 · Cited by 20
Self-citationVancomycin Dosing in Healthy-Weight, Overweight, and Obese Pediatric Patients
Eiland, L. S., & Sonawane, K. (2014) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-19.3.182 · Cited by 19
Vancomycin Pharmacokinetics and Pharmacodynamics during Short Daily Hemodialysis
Decker, B. S., Kays, M. B., Chambers, M., Kraus, M. A., Moe, S. M., & Sowinski, K. M. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03450410 · Cited by 19
Phillips, C. J., McKinnon, R. A., Woodman, R. J., & Gordon, D. (2017) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2017.09.010 · Cited by 19
Evaluation of glycopeptide use in nine French hospitals
Alfandari, S., Levent, T., Descamps, D., Hendricx, S., Bonenfant, C., Taines, V., Cattoen, C., Arimane, O., & Grandbastien, B. (2009) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2009.10.019 · Cited by 18
Vancomycin serum concentration during febrile neutropenia in patients with acute myeloid leukemia
Hochart, C., Berthon, C., Corm, S., Gay, J., Cliquennois, M., Tricot, S., & Alfandari, S. (2011) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2011.09.014 · Cited by 18
Irikura, M., Fujiyama, A., Saita, F., Fukushima, S., Kitaoka, H., Fukuda, T., Kawase, A., Kondo, Y., Ishitsuka, Y., Kondo, G., et al. (2011) · Pediatrics International · doi:10.1111/j.1442-200x.2011.03441.x · Cited by 17
Phillips, C. J., Wisdom, A. J., McKinnon, R. A., Woodman, R. J., & Gordon, D. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s176519 · Cited by 16
Predicting Maintenance Doses of Vancomycin for Hospitalized Patients Undergoing Hemodialysis
Nekidy, W. S. E., El‐Masri, M. M., Umstead, G. S., & Dehoorne-Smith, M. L. (2016) · The Canadian Journal of Hospital Pharmacy · doi:10.4212/cjhp.v69i5.1588 · Cited by 13
Lemaire, X., Valette, M., Dubreuil, L. J., Yazdanpanah, Y., Senneville, É., Loïez, C., Migаud, H., & Lemaire, X. (2010) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-010-0176-z · Cited by 11
Cited by
Antimicrobial resistance: One Health approach
Velazquez-Meza, M. E., Galarde-López, M., Carrillo-Quiróz, B., & Alpuche-Aranda, C. M. (2022) · Veterinary World · doi:10.14202/vetworld.2022.743-749 · Cited by 571
From Therapeutic Drug Monitoring to Model‐Informed Precision Dosing for Antibiotics
Wicha, S. G., Märtson, A., Nielsen, E. I., Koch, B. C. P., Friberg, L. E., Alffenaar, J., Minichmayr, I. K., & the International Society of Anti‐Infective Pharmacology (ISAP), T. P. S. G. O. T. E. S. O. C. M. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2202 · Cited by 322
Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis
Bai, A. D., Lo, C. K. L., Komorowski, A. S., Suresh, M., Guo, K., Garg, A., Tandon, P., Senecal, J., Del Corpo, O., Stefanova, I., et al. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.03.015 · Cited by 319
Woods, C. R., Bradley, J. S., Chatterjee, A., Copley, L. A., Robinson, J., Kronman, M. P., Arrieta, A., Fowler, S. L., Harrison, C., Carrillo-Marquez, M. A., et al. (2021) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piab027 · Cited by 308
Self-citationHe, N., Su, S., Ye, Z., Du, G., He, B., Li, D., Liu, Y., Yang, K., Zhang, X., Zhang, Y., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1536 · Cited by 155
Metadata
- Authors
- Rybak, M. J., Le, J., Lodise, T. P., Levine, D. P., Bradley, J. S., Liu, C., Mueller, B. A., Pai, M. P., Wong-Beringer, A., Rotschafer, J. C., Rodvold, K. A., Maples, H. D., & Lomaestro, B. M.
- Venue
- American Journal of Health-System Pharmacy
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-03-19
- Volume
- 77
- Issue
- 11
- Pages
- 835-864
- ISSN
- 1079-2082 (ISSN-L)
- 1535-2900
- OpenAlex
- W3012260518
- Cited by
- 1,202
- References
- 152
- FWCI
- 79.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.